MicroRNAs and mild cognitive impairment: A systematic review
Related Experiment Video
Updated: Feb 2, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Paola Piscopo1, Eleonora Lacorte2, Marco Feligioni3
1Dept of Neuroscience, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy.
Background:
Mild cognitive impairment (MCI) is usually described as an intermediate phase between normal cognition and dementia. Identifying the subjects at a higher risk of progressing from MCI to AD is essential to manage this condition. The diagnosis of MCI is mainly clinical. Several biomarkers have been proposed, but mostly for research purposes, as they are based on an invasive procedure to obtain the sample, such as cerebrospinal fluid (CSF). As a consequence, rapid and non-invasive biomarkers are needed to improve diagnosis. The objective of this systematic review is to summarize available evidence on the use of miRNAs as biomarkers in subjects with MCI.
Methods:
Relevant literature published up to June 2018 was retrieved searching the databases PubMed, ISI Web of Knowledge and the Cochrane Database. Only studies considering microRNAs (miRNAs) and a diagnosis of MCI were included. Data were extracted using a specifically-designed standardized form, and their methodological quality was assessed using QUADAS-2 and QUIPS.
Results:
Twenty-one studies of 153 retrieved articles met the predefined inclusion/exclusion criteria. Studies included participants ranging from 6 to 330. More than 40 miRNAs resulted as dysregulated, and miR-206 was the only miRNA that was found as differentially expressed in patients with MCI by more than two studies. However, these results have either not yet been confirmed in other independent cohorts, or data are still inconsistent. Inconsistencies among included studies could be due to several issues including the selection of participants, pre-analytical and analytical procedures, and statistical analyses.
Insights
MicroRNAs (miRNAs) show potential as non-invasive biomarkers for mild cognitive impairment (MCI). However, current evidence is inconsistent, highlighting the need for further research to validate their diagnostic utility in MCI progression.
Area of Science:
- Biomarkers
- Neuroscience
- Molecular Biology
Background:
- Mild cognitive impairment (MCI) represents a transitional stage between normal cognition and dementia.
- Accurate identification of individuals at high risk of progressing from MCI to Alzheimer's disease (AD) is crucial for effective management.
- Current MCI diagnosis relies on clinical assessment, with research biomarkers often requiring invasive procedures like cerebrospinal fluid (CSF) collection.
Purpose of the Study:
- To systematically review existing literature on the application of microRNAs (miRNAs) as biomarkers for diagnosing MCI.
- To assess the current evidence regarding the utility of miRNAs in identifying individuals with MCI.
Main Methods:
- A systematic literature search was conducted across PubMed, ISI Web of Knowledge, and Cochrane Database up to June 2018.
- Inclusion criteria focused on studies investigating microRNAs (miRNAs) in the context of MCI diagnosis.
- Methodological quality of included studies was evaluated using QUADAS-2 and QUIPS tools.
Main Results:
- Twenty-one studies involving 153 articles met the inclusion criteria, with participant numbers ranging from 6 to 330.
- Over 40 microRNAs (miRNAs) were identified as dysregulated in MCI.
- miR-206 was the only miRNA consistently found to be differentially expressed in MCI patients across multiple studies, though results require independent validation and show inconsistencies.
Conclusions:
- MicroRNAs (miRNAs) present a promising avenue for developing non-invasive biomarkers for mild cognitive impairment (MCI).
- Significant inconsistencies exist among current studies regarding miRNA expression in MCI, potentially due to variations in participant selection, sample handling, and analytical methods.
- Further research with standardized protocols and independent validation is necessary to establish the reliability of miRNAs as diagnostic biomarkers for MCI.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
Cognitive Dissonance
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Random and Systematic Errors

